NEUROENDOCRINE TUMOR LU-177-DOTATATE THERAPY

Course overview

LU 177 DOTATATE THERAPY IS A TREATMENT MODALITY USED TO MANAGE AND TREAT NEUROENDOCRINE TUMOR PATIENTS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR LU 177 DOTATATE THERAPY AS A VALUABLE AGENT IN THE MANAGEMENT OF NEUROENDOCRINE OR CARCINOID TUMORS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL, MULTIDISCIPLINARY TEAMS INVOLVED IN MANAGING PATIENTS WITH ADVANCED NEUROENDOCRINE TUMORS.